My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
Webinar - Reading Between the Lines: Living in Contract White Space
Tell a Friend About This EventTell a Friend
Webinar - Reading Between the Lines: Living in Contract White Space

When: Thursday, December 14, 2017
12:00 – 1:00 PM EST
Where: Online Webinar
United States
Contact: Brendan Ward

Online registration is closed.
« Go to Upcoming Event List  


Your team tirelessly negotiates a deal over many months. Both CEOs have high expectations for the value this alliance will create. The deal you struck covered all the bases and included your preferred terms and conditions. But, early in implementation, issues arise. The contract did not contemplate or provide for those issues, and now the collaboration is faltering. How do you navigate the white space between what the contract contemplates and the real-world developments in the alliance?

As ASAP kicks off a new partnership with the Licensing Executives Society (LES), this session presents a dialogue featuring insights and experience from a distinguished intellectual property transactional attorney and an accomplished alliance executive and pharmaceutical industry leader as they explore these issues, discuss strategies for resolution, and share best practices in alliance management. This session will:

  • Enable you to better anticipate problems, plan solutions, and devise comprehensive transactional strategies before the deal is signed
  • Provide insight and expert guidance in navigating contract white space, alliance governance, and issue resolution


Christine A. Carberry, CSAP
Chief Operating Officer | Keryx Biopharmaceuticals

Christine Carberry is a biopharmaceutical leader with the unique ability to transform strategy into results through the power of collaboration. She joined Keryx Biopharmaceutical in the beginning of 2017 as the chief operating officer. In her leadership role, she serves on the executive committee while leading initiatives in cross-functional integration, operational excellence, and program management. She heads the manufacturing, technical operations, quality and regulatory functions.

Prior to Keryx, she served as a senior vice president at FORUM Pharmaceuticals. At FORUM, she established the program & alliance management cross-functional matrix to integrate across the entire organization. She also led the CMC, supply chain, and quality functions.

At Biogen for over 25 years, Christine held positions of increasing responsibility as the company advanced from a biotechnology pioneer to an internationally recognized Fortune 500 company.

Christine is a Certified Strategic Alliance Professional (CSAP). She holds an M.S. in innovation and technology management from Boston University, Certificates in Management and Biotechnology Strategy from Harvard University, and a B.S. in biochemistry from the University of New Hampshire.

Andy Eibling, CSAP
Vice President, Alliance Management | Covance

Andy Eibling is currently Vice President of Alliance Management at Covance, Inc, the drug development division of LabCorp, the world's leading healthcare diagnostics company. He assumed leadership of Covance's Enterprise Alliance Management team in 2015. This team is responsible for Covance's largest alliance relationships that cross all service lines and for driving the development of an alliance management competency across the company.

Andy joined Covance in 2011 with responsibility for the ground-breaking alliance between Covance and Eli Lilly and Company. Spanning the drug development continuum, this global $1.6 billion partnership included activities from early drug discovery through post-launch clinical development. Prior to joining Covance, Andy spent over 24 years at Eli Lilly and Company, most recently implementing Lilly's partnering strategy with roles in Business Development and as a founding member of Lilly's pioneering Office of Alliance Management. During that time Andy managed a variety of alliances, ranging from early discovery technologies to global drug development alliances with Lilly ICOS, LLC for Cialis® and Amylin for Byetta®.

Andy is a member of the Association of Strategic Alliance Professionals, and a Certified Strategic Alliance Professional. He has spoken at numerous conferences and workshops, and his work on "Unique Aspects of Alliance Projects" was published by Wiley in 2010 in the book, Pharmaceutical and Biomedical Project Management in a Changing Global Environment. Andy has a BSME from Purdue University and MBA from Indiana University.

Brian O'Shaughnessy
Immediate Past President, Licensing Executives Society (USA & Canada), Inc.
Partner |Dinsmore & Shohl, LLP

Brian O'Shaughnessy is an internationally recognized authority in licensing and commercial transactions involving intellectual property rights. He is a Partner in the Intellectual Property Practice Group of Dinsmore & Shohl, LLP, residing in its Washington, DC office; and he is immediate past president and chair of the board of the Licensing Executives Society (USA and Canada), Inc.

Mr. O'Shaughnessy provides strategies for IP owners to maximize value from their portfolios by creating strong international IP portfolios, implementing prudent IP-risk avoidance strategies, and enforcing and/or defending IP rights in contested proceedings, including post-grant proceedings at the USPTO. He has been retained as a consulting and testifying expert witness in licensing disputes on behalf of private enterprise and the federal government. He works with life sciences companies in lifecycle management strategies, and in bringing and resolving Hatch-Waxman litigation. His 30 years of experience as an IP attorney afford a diverse perspective, and facilitate creative and cost-effective solutions to intellectual property management.

Brian has served on the LES USA & Canada Board of Trustees since 2007. His Board duties have included responsibility for the Society's public policy positions, amicus briefs, and external education, including congressional outreach. He has also served the LES Board as Trustee for Education; and he has been a long-time author and faculty member of various LES curriculum-based educational programs.

Brian has been acknowledged as among the "IAM Strategy 300", the world's leading IP strategists, and among the "The World's Leading Patent and Technology Licensing Lawyers" (IAM Magazine). In 2013, Brian was awarded the Outstanding Alumnus Award by his alma mater, Rochester Institute of Technology; and, in 2005, he was awarded the RIT College of Science Distinguished Alumnus Award.

For more information email us at or call +1-781-562-1630